Yukako Yokouchi

Yukako Yokouchi

Auto-generated profile, based on publicly available information

Yukako Yokouchi

Department of Pediatrics, Disaster Medical Center , Tokyo , Japan

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1998 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
ENE Noguchi
E Noguchi
MSM Shibasaki
M Shibasaki
TAT Arinami
T Arinami
KTK Takeda
K Takeda
YYY Yokouchi
Y Yokouchi
HHH Hamaguchi
H Hamaguchi

1 June 2000 in Genomics
Verified
Journal Article
Closed access
YYYukako Yokouchi
Yukako Yokouchi
YNYumi Nukaga
Yumi Nukaga
MSMasanao Shibasaki
Masanao Shibasaki
ENEmiko Noguchi
Emiko Noguchi
KKKazumi Kimura
Kazumi Kimura
TATadao Arinami
Tadao Arinami

1 January 2000 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JNJunko Nakayama
Junko Nakayama
KHKenzo Hamano
Kenzo Hamano
NINobuaki Iwasaki
Nobuaki Iwasaki
SNSatoko Nakahara
Satoko Nakahara
YHYumi Horigome
Yumi Horigome
TATadao Arinami
Tadao Arinami
Febrile seizures (FSs) represent the most common form of childhood seizure. In the Japanese population, the incidence rate is as high as 7%. It has been recognized that there is a significant genetic component for susceptibility to this type of seizure. Two putative FS loci, FEB1 (chromosome 8q13–q21) and FEB2 (chromosome 19p), have been mapped. Furthermore, a mutation in the voltage-gated sodium (Na+)-channel β1 subunit gene (SCN1B) at chromosome 19q13.1 was identified in a family with a clinical subset, termed generalized epilepsy with febrile seizures plus (GEFS+). These loci are linked to some large families. In this study, we conducted a genome-wide linkage search for FS in one large family with subsequent linkage confirmation in 39 nuclear families. Significant linkage was found at D5S644 by multipoint non-parametric analysis using GENEHUNTER (P = 5.4 × 10–6). Estimated λs at D5S644 was 2.5 according to maximum likelihood analysis. Significant linkage disequilibria with FS were observed at the markers D5S644, D5S652 and D5S2079 in 47 families by transmission disequilibrium tests. These findings indicate that there is a gene on chromosome 5q14–q15 that confers susceptibility to FSs and we call this gene FEB4.

15 July 2005 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ENEmiko Noguchi
Emiko Noguchi
YYYukako Yokouchi
Yukako Yokouchi
JZJiang Zhang
Jiang Zhang
KSKazuko Shibuya
Kazuko Shibuya
ASAkira Shibuya
Akira Shibuya
TATadao Arinami
Tadao Arinami
Rationale: Asthma is a common respiratory disease with complex genetic components. We previously reported strong evidence for linkage between mite-sensitive asthma and markers on chromosome 5q33. This area of linkage includes a region homologous to a mouse area that contains a locus involved in regulation of airway hyperreactivity. Objective: The aim of the present study is to identify asthma susceptibility genes on chromosome 5q33. Methods and Results: We performed mutation screening and association analyses of genes in the 9.4-Mb human linkage region. Transmission disequilibrium test analysis of 105 polymorphisms in 155 families with asthma revealed that six polymorphisms in cytoplasmic fragile X mental retardation protein (FMRP)–interacting protein 2 gene were associated significantly with the development of asthma (p = 0.000075; odds ratio, 5.9). These six polymorphisms were in complete linkage disequilibrium. In real-time quantitative polymerase chain reaction analysis, subjects homozygous for the haplotype overtransmitted to asthma-affected offspring showed significantly increased level of cytoplasmic FMRP interacting protein 2 gene expression in lymphocytes compared with ones heterozygous for the haplotype (p = 0.038). Conclusions: Our data suggest that cytoplasmic FMRP interacting protein 2 are associated with the development of atopic asthma in humans, and that targeting cytoplasmic FMRP interacting protein 2 could be a novel strategy for treating atopic asthma.

1 July 2002 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ENEmiko Noguchi
Emiko Noguchi
YYYukako Yokouchi
Yukako Yokouchi
MSMasanao Shibasaki
Masanao Shibasaki
MIMichharu Inudou
Michharu Inudou
SNSatoko Nakahara
Satoko Nakahara
TATadao Arinami
Tadao Arinami
Tumor necrosis factor (TNF) is a proinflammatory cytokine that participates in the inflammatory reaction in patients with asthma. The TNFA and TNFB genes, which encode TNF-α and TNF-β, respectively, are located within the region encoding the human major histocompatibility complex on chromosome 6p21.3, which showed linkage to atopic asthma in our genome-wide search. To determine whether polymorphisms in the 5′ flanking region of the TNFA gene (−1031C/T, −863C/A, and −857C/T) and an NcoI polymorphism in the TNFB gene (LTA NcoI) are associated with the development of asthma, we performed transmission disequilibrium tests of families identified through children with atopic asthma. Genotypes of families were determined by polymerase chain reaction–based restriction fragment length polymorphism or SNaPshot analysis. Transmission disequilibrium tests of 144 asthmatic families revealed that transmission of the −857C allele and the −1031T−863C−857C haplotype in the TNFA gene to asthma-affected offspring occurred more frequently than expected (−857C allele, p = 0.0055; −1031T−863C−857C haplotype, p = 0.0002). Our results suggest that TNFA or nearby genes, including those in the major histocompatibility complex region, may contribute to the development of asthma in the Japanese population.

1 November 2001 in Human Immunology
Verified
Journal Article
Closed access
ENEmiko Noguchi
Emiko Noguchi
YNYuumi Nukaga-Nishio
Yuumi Nukaga-Nishio
ZJZhang Jian
Zhang Jian
YYYukako Yokouchi
Yukako Yokouchi
MKMasashi Kamioka
Masashi Kamioka
TATadao Arinami
Tadao Arinami